BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6141198)

  • 1. The pharmacokinetics and antihistaminic of the H1 receptor antagonist hydroxyzine.
    Simons FE; Simons KJ; Frith EM
    J Allergy Clin Immunol; 1984 Jan; 73(1 Pt 1):69-75. PubMed ID: 6141198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic studies of the H1-receptor antagonist hydroxyzine in the elderly.
    Simons KJ; Watson WT; Chen XY; Simons FE
    Clin Pharmacol Ther; 1989 Jan; 45(1):9-14. PubMed ID: 2562944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics and pharmacodynamics of hydroxyzine in patients with primary biliary cirrhosis.
    Simons FE; Watson WT; Chen XY; Minuk GY; Simons KJ
    J Clin Pharmacol; 1989 Sep; 29(9):809-15. PubMed ID: 2572611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics and antihistaminic effects of brompheniramine.
    Simons FE; Frith EM; Simons KJ
    J Allergy Clin Immunol; 1982 Dec; 70(6):458-64. PubMed ID: 6128358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the H2-receptor antagonist cimetidine, on the pharmacokinetics and pharmacodynamics of the H1-receptor antagonists hydroxyzine and cetirizine in rabbits.
    Chen X; Simons FE; Simons KJ
    Pharm Res; 1994 Feb; 11(2):295-300. PubMed ID: 8165191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria.
    Simons FE; Sussman GL; Simons KJ
    J Allergy Clin Immunol; 1995 Mar; 95(3):685-93. PubMed ID: 7897151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous administration of hydroxyzine to healthy dogs.
    Bizikova P; Papich MG; Olivry T
    Vet Dermatol; 2008 Dec; 19(6):348-57. PubMed ID: 18980631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative antihistaminic and psychomotor effects of hydroxyzine and cetirizine.
    Gengo FM; Dabronzo J; Yurchak A; Love S; Miller JK
    Clin Pharmacol Ther; 1987 Sep; 42(3):265-72. PubMed ID: 2887328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of hydroxyzine and cetirizine following oral administration of hydroxyzine to exercised Thoroughbred horses.
    Knych HK; Weiner D; Steinmetz S; Flynn K; McKemie DS
    J Vet Pharmacol Ther; 2019 Nov; 42(6):617-623. PubMed ID: 31490561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of chronic administration of hydroxyzine on hydroxyzine pharmacokinetics in dogs.
    Simons KJ; Simons FE
    J Allergy Clin Immunol; 1987 Jun; 79(6):928-32. PubMed ID: 2884246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyzine from topical phospholipid liposomal formulations: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model.
    Elzainy AA; Gu X; Simons FE; Simons KJ
    AAPS PharmSci; 2003 Nov; 5(4):E28. PubMed ID: 15198516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic studies of the histamine H1-receptor antagonist ebastine in dogs.
    Puigdemont A; Queralt M; Jansat JM; Martinez-Tobed A
    J Pharm Pharmacol; 1994 Jul; 46(7):596-9. PubMed ID: 7996390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation of the H1-receptor antagonist triprolidine: pharmacokinetics and antihistaminic effects.
    Simons KJ; Singh M; Gillespie CA; Simons FE
    J Allergy Clin Immunol; 1986 Feb; 77(2):326-30. PubMed ID: 3944383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse central nervous system effects of older antihistamines in children.
    Simons FE; Fraser TG; Reggin JD; Roberts JR; Simons KJ
    Pediatr Allergy Immunol; 1996 Feb; 7(1):22-7. PubMed ID: 8792380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of H1-receptor antagonists in skin and serum.
    Simons FE; Murray HE; Simons KJ
    J Allergy Clin Immunol; 1995 Mar; 95(3):759-64. PubMed ID: 7897161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare.
    Meltzer EO; Gillman SA
    Allergy Asthma Proc; 2007; 28(1):67-73. PubMed ID: 17390761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and antipruritic effects of hydroxyzine in children with atopic dermatitis.
    Simons FE; Simons KJ; Becker AB; Haydey RP
    J Pediatr; 1984 Jan; 104(1):123-7. PubMed ID: 6361228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the suppressive effect of astemizole, terfenadine, and hydroxyzine on histamine-induced wheals and flares in humans.
    Gendreau-Reid L; Simons KJ; Simons FE
    J Allergy Clin Immunol; 1986 Feb; 77(2):335-40. PubMed ID: 3080511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The time course of action of three differing doses of noberastine, a novel H1-receptor antagonist, on histamine-induced skin wheals and the relationship to plasma drug concentrations in normal human volunteers.
    Wood-Baker R; Emanuel MB; Hutchinson K; Howarth PH
    Br J Clin Pharmacol; 1993 Feb; 35(2):166-70. PubMed ID: 8095149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of haemodialysis on the pharmacokinetics of cetirizine.
    Awni WM; Yeh J; Halstenson CE; Opsahl JA; Chung M; Matzke GR
    Eur J Clin Pharmacol; 1990; 38(1):67-9. PubMed ID: 1970299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.